acute myeloid leukemia

Seattle Genetics ends clinical trial of leukemia drug after ‘a higher rate of deaths’
Seattle Times, WA
Mon, 06/19/17 - 11:38 pm
Seattle Genetics
clinical trials
vadastuximab talirine
AML
acute myeloid leukemia
Novartis bags FDA OK for Rydapt, adding a new chemo combo drug for AML
Endpoints
Sat, 04/29/17 - 10:02 am
Novartis
FDA
Rydapt
chemotherapy
AML
acute myeloid leukemia
Seattle Genetics to resume trials as FDA lifts clinical hold
Yahoo/Reuters
Mon, 03/6/17 - 09:52 am
Seattle Genetics
clinical trials
FDA
vadastuximab talirine
AML
acute myeloid leukemia
Celgene, Agios beat a short path to an FDA decision on AML drug
Endpoints
Wed, 03/1/17 - 08:53 pm
Celgene
Agios
FDA
AML
enasidenib
acute myeloid leukemia
Bristol-Myers, Innate's Lirilumab Fails Trial (BMY)
Investopedia
Mon, 02/6/17 - 11:16 am
Bristol-Myers Squibb
Innate Pharma S.A.
lirilumab
acute myeloid leukemia
Seattle Genetics shares drop 13% on news of FDA holds on several early-stage clinical trials
Marketwatch
Tue, 12/27/16 - 01:47 pm
Seattle Genetics
FDA
vadastuximab talirine
acute myeloid leukemia
Seattle Genetics Initiates Phase 1 Trial of SGN-CD123A for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Yahoo
Mon, 09/19/16 - 09:51 am
Seattle Genetics
clinical trials
SGN-CD123A
AML
acute myeloid leukemia
Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene
TheStreet.com
Wed, 09/7/16 - 08:16 pm
Agios
FDA
Celgene
acute myeloid leukemia
AG-221
FDA slams drug maker for touting unapproved leukemia treatment to docs
Stat/Pharmalot
Wed, 09/7/16 - 11:55 am
FDA
Celator
off-label
Vyxeos
acute myeloid leukemia
Inside AbbVie’s Plans to Target Multiple Myeloma and Acute Myeloid Leukemia Segments with Venclexta
Market Realist
Mon, 07/11/16 - 10:50 am
AbbVie
Multiple Myeloma
acute myeloid leukemia
Venclexta
Novartis jumps into bi-specific antibody space with $150 million Xencor deal
BioPharma Dive
Tue, 06/28/16 - 11:14 am
Novartis
bispecific antibodies
Xencor
acute myeloid leukemia
B-cell malignancies
Celator Pharmaceuticals Nabs a Key FDA Designation, Readies for 2017
Motley Fool
Thu, 05/19/16 - 10:14 pm
Celator Pharmaceuticals
FDA
Vyxeos
AML
acute myeloid leukemia
Fortress Biotech Presents Positive Data from the Phase 1/2 Study of CNDO-109-Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia
Yahoo
Wed, 05/18/16 - 11:18 am
Fortress Biotech
clinical trials
CNDO-109
acute myeloid leukemia
Is This the End of Sunesis?
24/7 Wall St
Fri, 07/24/15 - 06:00 pm
Sunesis
FDA
AML
vosaroxin
acute myeloid leukemia
Tolero bags $14M to take its cancer drug to Phase III
Fierce Biotech
Fri, 08/8/14 - 11:52 am
Tolero Pharmaceuticals
alvocidib
acute myeloid leukemia
Boehringer cancer drug effective in mid-stage trial
Reuters
Tue, 07/8/14 - 10:26 am
Boehringer Ingelheim
acute myeloid leukemia
volasertib
Results from Phase III Study (AML-001) of VIDAZA® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at EHA
Yahoo/BusinessWire
Sat, 06/14/14 - 09:29 am
acute myeloid leukemia
leukemia
Vidaza
Celgene
Sunesis says encouraged by trial of Qinprezo
The Fly on the Wall
Mon, 06/2/14 - 11:07 am
Qinprexo
Sunesis
ASCO
acute myeloid leukemia
myelodysplastic syndrome
Ambit's Oncology Drug in Phase III
Yahoo/Zacks.com
Wed, 04/9/14 - 09:34 pm
Ambit Biosciences
quizartinib
acute myeloid leukemia
Agios' Experimental Leukemia Drug Makes Cancer Undetectable In Three Patients
Forbes
Mon, 04/7/14 - 08:34 am
Agios
AG-221
acute myeloid leukemia

Pages